DSM — Koninklijke DSM NV Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesBalancedLarge CapFalling Star

Annual income statement for Koninklijke DSM NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2018 December 31st	R2019 December 31st	2020 December 31st	R2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	9,267	7,998	8,106	7,269	8,390
Cost of Revenue
Gross Profit	3,405	2,764	2,776	2,612	2,690
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	8,022	7,126	7,444	6,558	7,708
Operating Profit	1,245	872	662	711	682
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,144	780	595	611	594
Provision for Income Taxes
Net Income After Taxes	958	638	492	488	470
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	1,077	758	506	1,676	1,700
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,069	750	499	1,670	1,694
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	6.69	4.61	4.88	5.36	2.97
Dividends per Share